Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Diabetes

Journal Scan / Research · June 15, 2017

Nasal Injection of Glucagon May Be Safer and Easier for Bystanders to Administer

Diabetes Technology & Therapeutics

 

Additional Info

Disclosure statements are available on the authors' profiles:

Diabetes Technology & Therapeutics
Faster Use and Fewer Failures With Needle-Free Nasal Glucagon Versus Injectable Glucagon in Severe Hypoglycemia Rescue: A Simulation Study
Diabetes Technol. Ther. 2017 May 30;[EPub Ahead of Print], JF Yale, H Dulude, M Egeth, CA Piché, M Lafontaine, D Carballo, R Margolies, E Dissinger, AR Shames, N Kaplowitz, MX Zhang, S Zhang, CB Guzman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading